AAAAAA

   
Results: 1-21 |
Results: 21
CYTOKINE GENE ACTIVITY IN AML CELLS IN-VIVO IN PATIENTS
Authors: GAO XZ BI SC COPRA H DEVEMY E VENUGOPAL P LI BR HSU WT LOEW J GALVEZ A GREGORY S YANG J HORVATH E PREISLER HD
Citation: Xz. Gao et al., CYTOKINE GENE ACTIVITY IN AML CELLS IN-VIVO IN PATIENTS, Leukemia research, 22(5), 1998, pp. 429-438
DOES LOW INDIVIDUAL OPERATOR CORONARY INTERVENTIONAL PROCEDURAL VOLUME CORRELATE WITH WORSE INSTITUTIONAL PROCEDURAL OUTCOME
Authors: KLEIN LW SCHAER GL CALVIN JE PALVAS B ALLEN J LOEW J URETZ E PARRILLO JE
Citation: Lw. Klein et al., DOES LOW INDIVIDUAL OPERATOR CORONARY INTERVENTIONAL PROCEDURAL VOLUME CORRELATE WITH WORSE INSTITUTIONAL PROCEDURAL OUTCOME, Journal of the American College of Cardiology, 30(4), 1997, pp. 870-877
CELL-CYCLE KINETIC-STUDIES IN 68 PATIENTS WITH MYELODYSPLASTIC SYNDROMES FOLLOWING INTRAVENOUS IODODEOXYURIDINE AND OR BROMODEOXYURIDINE/
Authors: RAZA A ALVI S BROADYROBINSON L SHOWEL M CARTLIDGE J MUNDLE SD SHETTY VT BOROK RZ DAR SE CHOPRA HK SPAN L PARCHARIDOU A HINES C GEZER S VENUGOPAL P LOEW J SHOWEL J ALSTON D HERNANDEZ B RIFKIN S ROBIN E SHAH R GREGORY SA
Citation: A. Raza et al., CELL-CYCLE KINETIC-STUDIES IN 68 PATIENTS WITH MYELODYSPLASTIC SYNDROMES FOLLOWING INTRAVENOUS IODODEOXYURIDINE AND OR BROMODEOXYURIDINE/, Experimental hematology, 25(6), 1997, pp. 530-535
EQUIVALENCE OF HISTONE H3 IN-SITU HYBRIDIZATION (HHISH) AND INTRAVENOUS ADMINISTRATION OF IUDR BRDU FOR ESTIMATING THE PERCENT OF S-PHASE CELLS IN NON-HODGKINS-LYMPHOMA (NHL)/
Authors: CHOPRA HK VENUGOPAL P KOTELNIKOV V SIVARAMAN S RILEY MB MEYER P LOEW J GREGORY SA RAZA A PREISLER HD
Citation: Hk. Chopra et al., EQUIVALENCE OF HISTONE H3 IN-SITU HYBRIDIZATION (HHISH) AND INTRAVENOUS ADMINISTRATION OF IUDR BRDU FOR ESTIMATING THE PERCENT OF S-PHASE CELLS IN NON-HODGKINS-LYMPHOMA (NHL)/, Blood, 90(10), 1997, pp. 3814-3814
COMBINATION OF PENTOXIFYLLINE (PTX), CIPROFLOXACIN (CIPRO), DEXAMETHASONE (PCD) WITH AMIFOSTINE IMPROVES INEFFECTIVE HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
Authors: RAZA A ANDRIC T QAWI H VENUGOPAL P GEZER S GREGORY SA HINES C MUNDLE S ALI A SHETTY V MATIVI BY DAR S LOEW J ROBIN EL KOZLOFF M GALVEZ A RIFKIN SD ALSTON D HERNANDEZ BM SHAH R
Citation: A. Raza et al., COMBINATION OF PENTOXIFYLLINE (PTX), CIPROFLOXACIN (CIPRO), DEXAMETHASONE (PCD) WITH AMIFOSTINE IMPROVES INEFFECTIVE HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), Blood, 90(10), 1997, pp. 367-367
NOVEL INSIGHTS INTO THE BIOLOGY OF MYELODYSPLASTIC SYNDROMES - EXCESSIVE APOPTOSIS AND THE ROLE OF CYTOKINES
Authors: RAZA A MUNDLE S SHETTY V ALVI S CHOPRA H SPAN L PARCHARIDOU A DAR S VENUGOPAL P BOROK R GEZER S SHOWEL J LOEW J ROBIN E RIFKIN S ALSTON D HERNANDEZ B SHAH R KAIZER H GREGORY S
Citation: A. Raza et al., NOVEL INSIGHTS INTO THE BIOLOGY OF MYELODYSPLASTIC SYNDROMES - EXCESSIVE APOPTOSIS AND THE ROLE OF CYTOKINES, International journal of hematology, 63(4), 1996, pp. 265-278
A PARADIGM SHIFT IN MYELODYSPLASTIC SYNDROMES
Authors: RAZA A MUNDLE S SHETTY V ALVI S CHOPRA H SPAN L PARCHARIDOU A DAR S VENUGOPAL P BOROK R GEZER S SHOWEL J LOEW J ROBIN E RIFKIN S ALSTON D HERNANDEZ B SHAH R KAIZER H GREGORY S PREISLER H
Citation: A. Raza et al., A PARADIGM SHIFT IN MYELODYSPLASTIC SYNDROMES, Leukemia, 10(10), 1996, pp. 1648-1652
ANTI-CYTOKINE THERAPY PRODUCES RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
Authors: RAZA A GEZER S GREGORY SA VENUGOPAL P KAIZER H DONG LM SPAN L HINES C THOMAS R ALVI S MUNDLE SD SHETTY V BOREK R LOEW J REZA S ROBIN EL RIFKIN SD ALSTON D HERNANDEZ BM SHAH R HSU WT DAR S PREISLER HD
Citation: A. Raza et al., ANTI-CYTOKINE THERAPY PRODUCES RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), Blood, 88(10), 1996, pp. 2310-2310
A MULTIVARIATE STUDY OF NON-HODGKINS-LYMPHOMA INVOLVING PROLIFERATION, APOPTOSIS, BCL-2 AND THE MICROENVIRONMENT
Authors: SHETTY V MUNDLE S SANOY A SANGHVI R LOEW J MARCUS B SHOWEL J GREGORY S RAZA A
Citation: V. Shetty et al., A MULTIVARIATE STUDY OF NON-HODGKINS-LYMPHOMA INVOLVING PROLIFERATION, APOPTOSIS, BCL-2 AND THE MICROENVIRONMENT, Leukemia & lymphoma, 18(3-4), 1995, pp. 273
APOPTOSIS IN BONE-MARROW BIOPSY SAMPLES INVOLVING STROMAL AND HEMATOPOIETIC-CELLS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: RAZA A GEZER S MUNDLE S GAO XZ ALVI S BOROK R RIFKIN S IFTIKHAR A SHETTY V PARCHARIDOU A LOEW J MARCUS B KHAN Z CHANEY C SHOWEL J GREGORY S PREISLER H
Citation: A. Raza et al., APOPTOSIS IN BONE-MARROW BIOPSY SAMPLES INVOLVING STROMAL AND HEMATOPOIETIC-CELLS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 86(1), 1995, pp. 268-276
CONTRASTING PATTERNS OF PROLIFERATION AND APOPTOSIS IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOGENOUS LEUKEMIAS
Authors: MUNDLE S PAYNE G SHETTY V MARCUS B LOEW J SHOTT S GREGORY S RAZA A
Citation: S. Mundle et al., CONTRASTING PATTERNS OF PROLIFERATION AND APOPTOSIS IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOGENOUS LEUKEMIAS, Experimental hematology, 22(8), 1994, pp. 764-764
NOVEL IN-SITU DOUBLE-LABELING FOR SIMULTANEOUS DETECTION OF PROLIFERATION AND APOPTOSIS
Authors: MUNDLE S IFTIKHAR A SHETTY V DAMERON S WRIGHTQUINONES V MARCUS B LOEW J GREGORY S RAZA A
Citation: S. Mundle et al., NOVEL IN-SITU DOUBLE-LABELING FOR SIMULTANEOUS DETECTION OF PROLIFERATION AND APOPTOSIS, The Journal of histochemistry and cytochemistry, 42(12), 1994, pp. 1533-1537
IN-VIVO EFFECTS OF RETINOIC ACID (RA) AND ALPHA-INTERFERON (IFN-ALPHA) ON PROLIFERATION AND APOPTOSIS IN MARROWS OF ACUTE MYELOGENOUS LEUKEMIA (AML) PATIENTS
Authors: MUNDLE S SAMIE A CHANEY C SHOTT S SHETTY V ALVI S SHOWEL J GREGORY S RIFKIN S LOEW J LARSON R GOLDBERG J PREISLER H RAZA A
Citation: S. Mundle et al., IN-VIVO EFFECTS OF RETINOIC ACID (RA) AND ALPHA-INTERFERON (IFN-ALPHA) ON PROLIFERATION AND APOPTOSIS IN MARROWS OF ACUTE MYELOGENOUS LEUKEMIA (AML) PATIENTS, Blood, 84(10), 1994, pp. 10000312-10000312
ASSESSMENT OF APOPTOSIS IN SERIAL BONE-MARROW (BM) BIOPSIES OF 53 PATIENTS WITH NEWLY-DIAGNOSED HIGH-RISK ACUTE MYELOGENOUS LEUKEMIA (HR-AML) FOLLOWING INDUCTION THERAPY
Authors: PARCHARIDOU A SAIKIA T MUNDLE S SHETTY V SHOTT S KOCHUPILLAI V GREGORY S LOEW J MARCUS B ALVI S LARSON R GOLDBERG J PREISLER H RAZA A
Citation: A. Parcharidou et al., ASSESSMENT OF APOPTOSIS IN SERIAL BONE-MARROW (BM) BIOPSIES OF 53 PATIENTS WITH NEWLY-DIAGNOSED HIGH-RISK ACUTE MYELOGENOUS LEUKEMIA (HR-AML) FOLLOWING INDUCTION THERAPY, Blood, 84(10), 1994, pp. 10000312-10000312
ROLE OF THE MICROENVIRONMENT AND MACROPHAGES IN UNDERSTANDING THE DYNAMICS OF MYELODYSPLASTIC SYNDROME (MDS)
Authors: SHETTY V MUNDLE S ALVI S SANOY A PAYNE G WRIGHTQUINONES V CHANEY C GREGORY S LOEW J MARCUS B SHOWEL J SHOTT S RIFKIN S PREISLER H RAZA A
Citation: V. Shetty et al., ROLE OF THE MICROENVIRONMENT AND MACROPHAGES IN UNDERSTANDING THE DYNAMICS OF MYELODYSPLASTIC SYNDROME (MDS), Blood, 84(10), 1994, pp. 10000314-10000314
EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE - MACROPHAGE-COLONY-STIMULATING FACTOR (RHGM-CSF) ON APOPTOSIS AND CELL-CYCLE KINETICS IN NEWLY-DIAGNOSED HIGH-RISK PATIENTS WITH ACUTE MYELOID-LEUKEMIA (HR-AML)
Authors: SAMIE A ALVI S MUNDLE S SHETTY V GREGORY S LOEW J LARSON R GOLDBERG J PREISLER H RAZA A
Citation: A. Samie et al., EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE - MACROPHAGE-COLONY-STIMULATING FACTOR (RHGM-CSF) ON APOPTOSIS AND CELL-CYCLE KINETICS IN NEWLY-DIAGNOSED HIGH-RISK PATIENTS WITH ACUTE MYELOID-LEUKEMIA (HR-AML), Blood, 84(10), 1994, pp. 10000586-10000586
DNA LADDERING AND IN-SITU END LABELING (ISEL) OF FRAGMENTED DNA SIMULTANEOUSLY DEMONSTRATE HIGH APOPTOSIS IN MYELODYSPLASTIC SYNDROMES (MDS) BUT LOW IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: GAO X MUNDLE S ALVI S MARCUS B LOEW J GREGORY S RIFKIN S SHOWEL J PREISLER H RAZA A
Citation: X. Gao et al., DNA LADDERING AND IN-SITU END LABELING (ISEL) OF FRAGMENTED DNA SIMULTANEOUSLY DEMONSTRATE HIGH APOPTOSIS IN MYELODYSPLASTIC SYNDROMES (MDS) BUT LOW IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000605-10000605
DIRECT RELATIONSHIP OF REMISSION DURATION TO POST CHEMOTHERAPY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN 55 NEWLY-DIAGNOSED HIGH-RISK ACUTE MYELOID-LEUKEMIA (AML) PATIENTS
Authors: SHETTY V KOCHUPILLAI V SAIKIA T GREGORY S LOEW J ALVI S LARSON R GOLDBERG J SHOTT S PREISLER H RAZA A
Citation: V. Shetty et al., DIRECT RELATIONSHIP OF REMISSION DURATION TO POST CHEMOTHERAPY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN 55 NEWLY-DIAGNOSED HIGH-RISK ACUTE MYELOID-LEUKEMIA (AML) PATIENTS, Blood, 84(10), 1994, pp. 10000625-10000625
INCREASED APOPTOSIS AS THE SIGNIFICANT CAUSE OF INEFFECTIVE HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: RAZA A GREGORY S MUNDLE S SHETTY V ALVI S MARCUS B LOEW J RIFKIN S SHOWEL J PREISLER H
Citation: A. Raza et al., INCREASED APOPTOSIS AS THE SIGNIFICANT CAUSE OF INEFFECTIVE HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES (MDS), Blood, 84(10), 1994, pp. 10000636-10000636
CORRELATION BETWEEN TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) AND MACROPHAGES IN THE TUMOR MICROENVIRONMENT OF LYMPH-NODES FROM 31 PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL)
Authors: SANGHVI R SHETTY V SANOY A ALVI S LOEW J GREGORY S SHOTT S SHOWEL J MILLIKAN K CHANEY C WRIGHTQUINONES V RAZA A
Citation: R. Sanghvi et al., CORRELATION BETWEEN TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) AND MACROPHAGES IN THE TUMOR MICROENVIRONMENT OF LYMPH-NODES FROM 31 PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL), Blood, 84(10), 1994, pp. 10000647-10000647
SIMULTANEOUS ASSESSMENT OF PROLIFERATION AND APOPTOSIS IN-SITU IN NON-HODGKINS-LYMPHOMA (NHL)
Authors: SHETTY V MUNDLE S IFTIKHAR A KHAN Z DANG R CHUNG E CHERTOW D MARCUS B LOEW J CHANEY C ADLER S SHOWEL J GREGORY S RAZA A
Citation: V. Shetty et al., SIMULTANEOUS ASSESSMENT OF PROLIFERATION AND APOPTOSIS IN-SITU IN NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000579-10000579
Risultati: 1-21 |